Literature DB >> 33617778

Insurance coverage and financing landscape for HIV treatment and prevention in the USA.

Jennifer Kates1, Lindsey Dawson2, Tim H Horn3, Amy Killelea3, Nicole C McCann4, Jeffrey S Crowley5, Rochelle P Walensky6.   

Abstract

In 2010, the US health insurance system underwent one of its most substantial transformations with the passage of the Affordable Care Act, which increased coverage for millions of people in the USA, including those with and at risk of HIV. Even so, the system of HIV care and prevention services in the USA is a complex patchwork of payers, providers, and financing mechanisms. People with HIV are primarily covered by Medicaid, Medicare, private insurance, or a combination of these; many get care through other programmes, particularly the Ryan White HIV/AIDS Program, which serves as the nation's safety net for people with HIV who remain uninsured or underinsured but offers modest to no support for prevention services. While uninsurance has drastically declined over the past decade, the USA trails other high-income countries in key HIV-specific metrics, including rates of viral suppression. In this paper in the Series, we provide an overview of the coverage and financing landscape for HIV treatment and prevention in the USA, discuss how the Affordable Care Act has changed the domestic health-care system, examine the major programmes that provide coverage and services, and identify remaining challenges.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Year:  2021        PMID: 33617778     DOI: 10.1016/S0140-6736(21)00397-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  4 in total

1.  The Historic Elimination of Mother-to-Child HIV and Syphilis Transmission in Puerto Rico.

Authors:  Sten H Vermund; Irma Febo
Journal:  P R Health Sci J       Date:  2021-03       Impact factor: 0.705

2.  Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide for Human Immunodeficiency Virus Preexposure Prophylaxis at a Boston Community Health Center.

Authors:  Julia L Marcus; Kenneth Levine; Whitney C Sewell; Patricia Solleveld; Kenneth H Mayer; Douglas S Krakower
Journal:  Open Forum Infect Dis       Date:  2021-08-05       Impact factor: 3.835

3.  Trends in Out-of-Pocket Costs for Naloxone by Drug Brand and Payer in the US, 2010-2018.

Authors:  Evan D Peet; David Powell; Rosalie Liccardo Pacula
Journal:  JAMA Health Forum       Date:  2022-08-05

4.  Obamacare: A bibliometric perspective.

Authors:  Alvaro Carrasco-Aguilar; José Javier Galán; Ramón Alberto Carrasco
Journal:  Front Public Health       Date:  2022-08-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.